SCHEMBL30255484

SCHEMBL30255484

Cc1cc(Nc2ncnc3sc(C)cc23)n[nH]1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.56
FGFR1 P11362 1/20 0.54
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
GAA P10253 1/20 0.53
PIP4K2C Q8TBX8 2/20 0.53
PIP5K1C O60331 1/20 0.53
PIP4K2A P48426 1/20 0.53
RAB9A P51151 3/20 0.51
NPC1 O15118 2/20 0.51
POLB P06746 1/20 0.50
CLK1 P49759 1/20 0.48
HTT P42858 1/20 0.45
HSD17B10 Q99714 1/20 0.45
IRAK4 Q9NWZ3 1/20 0.44
AURKA O14965 4/20 0.43
AURKB Q96GD4 3/20 0.43
PLK4 O00444 1/20 0.41
PAK4 O96013 1/20 0.41
GALR3 O60755 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30379291 0.80 PIP4K2A (0.51) MAPK1MEN1KMT2AGAAPIP4K2C
SCHEMBL4184328 0.78 PLK4 (0.61) FGFR1MEN1KMT2AHTTHSD17B10
SCHEMBL29997075 0.73 AURKA (0.62) AURKAAURKB
SCHEMBL30353143 0.73 MEN1 (0.51) FGFR1MEN1KMT2AHTTHSD17B10
SCHEMBL16363312 0.72 FGFR1 (0.79) MAPK1FGFR1MEN1KMT2AGAA
SCHEMBL7253942 0.72 MAPK1 (0.59) MAPK1FGFR1MEN1KMT2AGAA
SCHEMBL30353126 0.72 MEN1 (0.50) FGFR1MEN1KMT2AHTTHSD17B10
SCHEMBL24197138 0.71 RAB9A (0.57) MAPK1FGFR1MEN1KMT2AGAA
SCHEMBL30353167 0.71 MEN1 (0.56) FGFR1MEN1KMT2AHTTHSD17B10
SCHEMBL166340 0.70 NTRK1 (0.45) AURKAAURKBPLK4PAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043863-A1 HETEROAROMATIC DERIVATIVES FOR USE AS REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043863-A1 HETEROAROMATIC DERIVATIVES FOR USE AS REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF WEE2, WEE1, RORB MAPK1 225/4885FGFR1 916/4885MEN1 2377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.